BDBM645710 (2,5-dioxa-8-azaspiro[3.5]nonan-8- yl)(8-(2-(2,2,2- trifluoroethoxy)phenyl)-6- (trifluoromethyl)imidazo[1,2- a]pyridin-2-yl)methanone::US20240018140, Compound 51

SMILES FC(F)(F)COc1ccccc1-c1cc(cn2cc(nc12)C(=O)N1CCOC2(COC2)C1)C(F)(F)F

InChI Key InChIKey=QDVBWGFSZXFSMZ-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 645710   

TargetCeramide glucosyltransferase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM645710(US20240018140, Compound 51 | (2,5-dioxa-8-azaspiro...)
Affinity DataEC50:  0.510nMAssay Description:Using Promega's UDP-Glo Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent